Complex Combination of Pulmonary Embolism, Stroke, and ST-Segment Elevation Myocardial Infarction in Young Patient with Recent COVID-19 Infection and Newly Diagnosed Lung Carcinoma

1 Kumbhani DJ, Cannon CP, Beavers CJ, Bhatt DL, Cuker A, Gluckman TJ, et al. 2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention or with atherosclerotic cardiovascular disease: A report of the American college of cardiology solution set oversight committee. J Am Coll Cardiol. 2021;77(5):629-58. https://doi.org/10.1016/j.jacc.2020.09.011 PMid:33250267 Search in Google Scholar

2 Hirmerová J. Homocysteine and venous thromboembolism-is there any link? Cor et Vasa. 2013;55(3):e248-58. https://doi.org/10.1016/j.crvasa.2013.01.007 Search in Google Scholar

3 Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: An overview. Arch Pathol Lab Med. 2007;131(6):872-84. https://doi.org/10.5858/2007-131-872-HATAO Search in Google Scholar

4 Lijfering WM, Brouwer JL, Veeger NJ, Bank I, Coppens M, Middeldorp S, et al. Selective testing for thrombophilia in patients with first venous thrombosis: Results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood. 2009;113(21):5314-22. https://doi.org/10.1182/blood-2008-10-184879 PMid:19139080 Search in Google Scholar

5 Simone B, De Stefano V, Leoncini E, Zacho J, Martinelli I, Emmerich J, et al. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: A meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol. 2013;28(8):621-47. https://doi.org/10.1007/s10654-013-9825-8 PMid:23900608 Search in Google Scholar

6 Carmona-Bayonas A, Gómez D, de Castro EM, Segura PP, Langa JM, Jimenez-Fonseca P, et al. A snapshot of cancer-associated thromboembolic disease in 2018-2019: First data from the TESEO prospective registry. Eur J Intern Med. 2020;78:41-49. https://doi.org/10.1016/j.ejim.2020.05.031 PMid:32482596 Search in Google Scholar

7 Hamza MS, Mousa SA. Cancer-Associated Thrombosis: Risk Factors, Molecular Mechanisms, Future Management. Clin Appl Thromb Hemost. 2020;26:1076029620954282. https://doi.org/10.1177/1076029620954282 PMid:32877229 Search in Google Scholar

8 Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res. 2010;125(6):490-3. http://doi.org/10.1016/j.thromres.2009.12.023 PMid:20097409 Search in Google Scholar

9 Bonaventura A, Vecchié A, Dagna L, Martinod K, Dixon DL, Van Tassell BW. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21(5):319-29. https://doi.org/10.1038/s41577-021-00536-9 PMid:33824483 Search in Google Scholar

10 Hussain A, Minhas A, Sarwar U, Tahir H. Triple antithrombotic therapy (triple therapy) after percutaneous coronary intervention in chronic anticoagulation: A literature review. Cureus. 2022;14(2):e21810. http://doi.org/10.7759/cureus.21810 PMid:35261831 Search in Google Scholar

11 Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77. http://doi.org/10.1093/eurheartj/ehx393 PMid:28886621 Search in Google Scholar